Eli Lilly (LLY) Exchange Rate Effect (2009 - 2026)

Eli Lilly (LLY) has reported Exchange Rate Effect for 18 consecutive years, with $67.0 million the latest figure, recorded in Q1 2026.

• Exchange Rate Effect for Q1 2026 came in at $67.0 million, down 49.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $307.0 million (up 337.07% YoY), and the FY2025 annual result was $372.0 million, up 225.25% from the prior year.
• Exchange Rate Effect was $67.0 million for Q1 2026 at Eli Lilly, up from -$67.1 million in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $275.4 million in Q2 2025 and troughed at -$428.8 million in Q4 2024.
• Average Exchange Rate Effect over 5 years is $8.4 million, with a median of $9.2 million recorded in 2023.
• Year-over-year, Exchange Rate Effect plunged 906.98% in 2022 and jumped 4181.13% in 2024.
• Over 5 years, Exchange Rate Effect stood at -$128.2 million in 2022, then surged by 201.17% to $129.7 million in 2023, then slumped by 430.61% to -$428.8 million in 2024, then jumped by 84.35% to -$67.1 million in 2025, then surged by 199.85% to $67.0 million in 2026.
• Per Business Quant data, the three most recent Exchange Rate Effect figures were $67.0 million in Q1 2026, -$67.1 million in Q4 2025, and $31.7 million in Q3 2025.